Cargando…

Angiogenic cytokines and their influence on circulating tumour cells in sera of patients with the primary diagnosis of breast cancer before treatment

BACKGROUND: Circulating tumour cells (CTCs) have been found to be a prognostic marker for reduced disease free survival, breast cancer–specific survival, and overall survival before the start of systemic treatment. METHODS: A total of 200 patients’ sera were included in this study, 100 patients bein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vilsmaier, Theresa, Rack, Brigitte, Janni, Wolfgang, Jeschke, Udo, Weissenbacher, Tobias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964055/ https://www.ncbi.nlm.nih.gov/pubmed/27464822 http://dx.doi.org/10.1186/s12885-016-2612-7

Ejemplares similares

Interleukin 15 and Eotaxin correlate with the outcome of breast cancer patients vice versa independent of CTC status
por: Vilsmaier, Theresa, et al.
Publicado: (2020)

Multicentric and multifocal versus unifocal breast cancer: differences in the expression of E-cadherin suggest differences in tumor biology
por: Weissenbacher, Tobias, et al.
Publicado: (2013)

Prognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas
por: Schindlbeck, Christian, et al.
Publicado: (2005)

Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma – What is the Role of Liquid Biopsy in Breast Cancer?
por: Polasik, Arkadius, et al.
Publicado: (2017)

Fluorescence Analysis of Vitamin D Receptor Status of Circulating Tumor Cells (CTCS) in Breast Cancer: From Cell Models to Metastatic Patients
por: Zhang, Xi, et al.
Publicado: (2017)

Circulating microRNAs: promising breast cancer biomarkers - authors' response
por: Roth, Carina, et al.
Publicado: (2011)

Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer
por: Roth, Carina, et al.
Publicado: (2010)

Circulating Tumor Cells in Breast Cancer Patients: A Balancing Act between Stemness, EMT Features and DNA Damage Responses
por: Heitmeir, Benedikt, et al.
Publicado: (2022)

Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients
por: Stückrath, Isabel, et al.
Publicado: (2015)

Expression and prognostic value of circulating angiogenic cytokines in pancreatic cancer
por: Rahbari, Nuh N, et al.
Publicado: (2011)

Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients.
por: Dirix, L. Y., et al.
Publicado: (1997)

Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression
por: Roth, Carina, et al.
Publicado: (2011)

Are Circulating Tumor Cells (CTCs) Ready for Clinical Use in Breast Cancer? An Overview of Completed and Ongoing Trials Using CTCs for Clinical Treatment Decisions
por: Schochter, Fabienne, et al.
Publicado: (2019)

Binding of galectin-1 to breast cancer cells MCF7 induces apoptosis and inhibition of proliferation in vitro in a 2D- and 3D- cell culture model
por: Geiger, Pamina, et al.
Publicado: (2016)

Detection of Circulating Tumour Cells from Blood of Breast Cancer Patients via RT-qPCR
por: Andergassen, Ulrich, et al.
Publicado: (2013)

Syndecan-1 knock-down in decidualized human endometrial stromal cells leads to significant changes in cytokine and angiogenic factor expression patterns
por: Baston-Büst, Dunja M, et al.
Publicado: (2010)

L-Dopa-Decarboxylase (DDC) Is a Positive Prognosticator for Breast Cancer Patients and Epinephrine Regulates Breast Cancer Cell (MCF7 and T47D) Growth In Vitro According to Their Different Expression of G(i)- Protein- Coupled Receptors
por: Tremmel, Eileen, et al.
Publicado: (2020)

Postoperative course and prognostic value of circulating angiogenic cytokines after pancreatic cancer resection
por: Yang, Cui, et al.
Publicado: (2017)

Effects of definitive chemoradiation on circulating immunologic angiogenic cytokines in head and neck cancer patients
por: Sridharan, Vishwajith, et al.
Publicado: (2016)

Angiogenic activity of sera from interstitial lung disease patients in relation to pulmonary function
por: Zielonka, TM, et al.
Publicado: (2010)

Immunogenomic Identification for Predicting the Prognosis of Cervical Cancer Patients
por: Wang, Qun, et al.
Publicado: (2021)

The role of EP-2 receptor expression in cervical intraepithelial neoplasia
por: Schmoeckel, Elisa, et al.
Publicado: (2020)

Hormone Receptor Expression in Multicentric/Multifocal versus Unifocal Breast Cancer: Especially the VDR Determines the Outcome Related to Focality
por: Zati zehni, Alaleh, et al.
Publicado: (2019)

Effects of matcha tea extract on cell viability and peroxisome proliferator-activated receptor γ expression on T47D breast cancer cells
por: Keckstein, Simon, et al.
Publicado: (2022)

Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study
por: Müller, Volkmar, et al.
Publicado: (2012)

Angiogenic activity of sera from interstitial lung disease patients in relation to clinical and radiological changes
por: Zielonka, TM, et al.
Publicado: (2009)

Rationale and description of a lifestyle intervention programme to achieve moderate weight loss in women with non-metastatic breast cancer: the lifestyle intervention part of the SUCCESS C Study
por: Hauner, Dagmar, et al.
Publicado: (2020)

Proceedings: Tumour antigen in human cancer patients' sera.
por: Bowen, J. G.
Publicado: (1975)

The Agglutination of Tumour Cells In Vitro by Sera from Tumour Patients and Pregnant Women
por: Tal, C., et al.
Publicado: (1964)

Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer
por: Müller, Volkmar, et al.
Publicado: (2011)

LKB1 pro‐oncogenic activity triggers cell survival in circulating tumor cells
por: Trapp, Elisabeth Katharina, et al.
Publicado: (2017)

Estrogen Receptor and HER2 Status on Disseminated Tumor Cells and Primary Tumor in Patients with Early Breast Cancer
por: Jäger, Bernadette A.S., et al.
Publicado: (2015)

Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide
por: Borghini, Annalisa, et al.
Publicado: (2015)

Higher CCL22+ Cell Infiltration is Associated with Poor Prognosis in Cervical Cancer Patients
por: Wang, Qun, et al.
Publicado: (2019)

Cytoplasmic Colocalization of RXRα and PPARγ as an Independent Negative Prognosticator for Breast Cancer Patients
por: Shao, Wanting, et al.
Publicado: (2022)

CCL22-Polarized TAMs to M2a Macrophages in Cervical Cancer In Vitro Model
por: Wang, Qun, et al.
Publicado: (2022)

Influence of maternal age, gestational age and fetal gender on expression of immune mediators in amniotic fluid
por: Weissenbacher, Tobias, et al.
Publicado: (2012)

Value of Candida polymerase chain reaction and vaginal cytokine analysis for the differential diagnosis of women with recurrent vulvovaginitis.
por: Weissenbacher, S, et al.
Publicado: (2000)

EP4 as a Negative Prognostic Factor in Patients with Vulvar Cancer
por: Buchholz, Anna, et al.
Publicado: (2021)

The Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor Cells
por: Kölbl, Alexandra C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ef9oas9b931kt28liag2b61cap